Suppr超能文献

[左肺切除联合颈静脉注射野百合碱吡咯诱导的肺动脉高压小鼠模型的肺血管重塑特征]

[Pulmonary Vascular Remodeling Characteristics of Pulmonary Arterial Hypertension Mouse Model Induced by Left Pneumonectomy and Jugular Vein Injection of Monocrotaline Pyrrole].

作者信息

Gu Li, Liu Cai-Jun, Xie Liang, Gu Ling, Yu Li, Liu Han-Min

机构信息

Key Laboratory of Birth Defects and Related Diseases of Women and Children of the Ministry of Education, Sichuan University, Chengdu 610041, China.

Department of Pediatrics, the First People's Hospital of Yibin, Yibin 644000, China.

出版信息

Sichuan Da Xue Xue Bao Yi Xue Ban. 2022 Sep;53(5):821-827. doi: 10.12182/20220960508.

Abstract

OBJECTIVE

To compare and investigate the differences and characteristics of pulmonary vascular remodeling in three mouse models of pulmonary arterial hypertension (PAH) constructed by left pneumonectomy, jugular vein injection of monocrotaline pyrrole, and left pneumonectomy combined with jugular vein injection of monocrotaline pyrrole, to explore for a PAH animal model that approximates the clinical pathogenesis of PAH, and to create a model that will provide sound basis for thorough investigation into the pathogenesis of severe PAH.

METHODS

59 male C57/BL mice (10-12 weeks, 24-30 g) were randomized into four groups, a control group ( =9), a group that had left pneumonectomy (PE, =15), a group that had jugular vein injection of monocrotaline pyrrole (MCTP, =15), and the last group that had left pneumonectomy combined with jugular injection of monocrotaline pyrrole (P+M, =20). To evaluate the effect of modeling and the characteristics of pulmonary vascular remodeling, hemodynamic and morphological parameters, including right ventricular systolic pressure (RVSP), right ventricle/(left ventricle plus septum) (RV/LV+S), percent of wall thickness in the pulmonary artery (WT%), muscularization of non-muscular arteries, neointima formation, and vascular obstruction score (VOS), were measured in each group.

RESULTS

  1. Compared with those of the control group, the RVSP, RV/LV+S, WT%, and the degree of small pulmonary arteries muscularization in the P+M group were significantly increased ( <0.01). The MCTP group had just slightly higher findings for these indicators ( <0.05), while no significant change in these indicators was observed in the PE group ( >0.05). 2) Neointima formation in the acinus pulmonary arteries, which caused obvious stenosis of the lumen, was observed in the P+M group, the VOS being 1.25±0.80 points ( <0.001). In contrast, neointima formation was not observed in the MCTP group or the PE groups, the VOS being 0 point ( >0.05).

CONCLUSION

Left pneumonectomy combined with jugular intravenous injection of MCTP could induce severe PAH formation in mouse. The model provides a good simulation of neointima formation, the characteristic pathological change of clinical severe PAH.

摘要

目的

比较并研究通过左肺切除术、颈静脉注射野百合碱吡咯以及左肺切除术联合颈静脉注射野百合碱吡咯构建的三种肺动脉高压(PAH)小鼠模型中肺血管重塑的差异和特征,探索一种接近PAH临床发病机制的PAH动物模型,并创建一个能为深入研究重度PAH发病机制提供可靠依据的模型。

方法

将59只雄性C57/BL小鼠(10 - 12周龄,24 - 30克)随机分为四组,即对照组(n = 9)、左肺切除组(PE,n = 15)、颈静脉注射野百合碱吡咯组(MCTP,n = 15)和左肺切除联合颈静脉注射野百合碱吡咯组(P + M,n = 20)。为评估建模效果和肺血管重塑特征,测量了每组的血流动力学和形态学参数,包括右心室收缩压(RVSP)、右心室/(左心室加室间隔)(RV/LV + S)、肺动脉壁厚度百分比(WT%)、无肌型动脉肌化、新生内膜形成以及血管阻塞评分(VOS)。

结果

1)与对照组相比,P + M组的RVSP、RV/LV + S、WT%以及小肺动脉肌化程度显著增加(P < 0.01)。MCTP组这些指标略高(P < 0.05),而PE组这些指标无显著变化(P > 0.05)。2)在P + M组观察到腺泡肺动脉新生内膜形成,导致管腔明显狭窄,VOS为1.25±0.80分(P < 0.001)。相比之下,MCTP组和PE组未观察到新生内膜形成,VOS为0分(P > 0.05)。

结论

左肺切除联合颈静脉注射MCTP可诱导小鼠形成重度PAH。该模型很好地模拟了新生内膜形成,这是临床重度PAH的特征性病理变化。

相似文献

2
Pneumonectomy combined with SU5416 or monocrotaline pyrrole does not cause severe pulmonary hypertension in mice.
Am J Physiol Lung Cell Mol Physiol. 2024 Aug 1;327(2):L250-L257. doi: 10.1152/ajplung.00105.2024. Epub 2024 May 29.
3
Endothelial fate mapping in mice with pulmonary hypertension.
Circulation. 2014 Feb 11;129(6):692-703. doi: 10.1161/CIRCULATIONAHA.113.003734. Epub 2013 Nov 7.
6
[Fasudil reverses monocrotaline-induced pulmonary hypertension in rats].
Zhonghua Xin Xue Guan Bing Za Zhi. 2013 Mar;41(3):239-44.

本文引用的文献

1
SETD3 negatively regulates VEGF expression during hypoxic pulmonary hypertension in rats.
Hypertens Res. 2018 Sep;41(9):691-698. doi: 10.1038/s41440-018-0068-7. Epub 2018 Jun 27.
2
FOXM1 promotes pulmonary artery smooth muscle cell expansion in pulmonary arterial hypertension.
J Mol Med (Berl). 2018 Feb;96(2):223-235. doi: 10.1007/s00109-017-1619-0. Epub 2017 Dec 30.
4
Endothelial fate mapping in mice with pulmonary hypertension.
Circulation. 2014 Feb 11;129(6):692-703. doi: 10.1161/CIRCULATIONAHA.113.003734. Epub 2013 Nov 7.
5
The monocrotaline model of pulmonary hypertension in perspective.
Am J Physiol Lung Cell Mol Physiol. 2012 Feb 15;302(4):L363-9. doi: 10.1152/ajplung.00212.2011. Epub 2011 Sep 30.
6
Combination of sildenafil and simvastatin ameliorates monocrotaline-induced pulmonary hypertension in rats.
Pulm Pharmacol Ther. 2010 Oct;23(5):456-64. doi: 10.1016/j.pupt.2010.02.003. Epub 2010 Feb 23.
7
Pulmonary arterial hypertension in congenital heart disease: an epidemiologic perspective from a Dutch registry.
Int J Cardiol. 2007 Aug 21;120(2):198-204. doi: 10.1016/j.ijcard.2006.09.017. Epub 2006 Dec 19.
8
Involvement of integrins, MAPK, and NF-kappaB in regulation of the shear stress-induced MMP-9 expression in endothelial cells.
Biochem Biophys Res Commun. 2007 Feb 2;353(1):152-8. doi: 10.1016/j.bbrc.2006.12.002. Epub 2006 Dec 8.
9
[Pulmonary arterial hypertension].
Rev Mal Respir. 2005 Sep;22(4):651-66. doi: 10.1016/s0761-8425(05)85616-5.
10
Pulmonary arterial hypertension.
N Engl J Med. 2004 Oct 14;351(16):1655-65. doi: 10.1056/NEJMra035488.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验